These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 1603193)
41. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia]. Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343 [TBL] [Abstract][Full Text] [Related]
42. Neurological Deficits After Lithium Intoxication in a Bipolar Woman With Catatonia Treated With ECT. Medda P; Socci C; Toni C; Pergentini I; Forfori F; Giorgi FS; Perugi G J Clin Psychopharmacol; 2018 Aug; 38(4):405-407. PubMed ID: 29912800 [No Abstract] [Full Text] [Related]
43. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor. Jarrett P; Rademaker M; Havill J; Pullon H Clin Exp Dermatol; 1997 May; 22(3):146-7. PubMed ID: 9425696 [TBL] [Abstract][Full Text] [Related]
44. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
45. Etofenamate associated with Lyell syndrome: a case report. Golcuk Y; Oray D; Atilla OD; Tefennioglu N Clin Toxicol (Phila); 2010 Jun; 48(5):471-2. PubMed ID: 20586575 [TBL] [Abstract][Full Text] [Related]
46. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Yang Y; Xu J; Li F; Zhu X Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409 [TBL] [Abstract][Full Text] [Related]
47. Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics. Consoli A; Benmiloud M; Wachtel L; Dhossche D; Cohen D; Bonnot O J ECT; 2010 Dec; 26(4):259-65. PubMed ID: 21099377 [TBL] [Abstract][Full Text] [Related]
48. Self-injury in autism as an alternate sign of catatonia: implications for electroconvulsive therapy. Wachtel LE; Dhossche DM Med Hypotheses; 2010 Jul; 75(1):111-4. PubMed ID: 20202760 [TBL] [Abstract][Full Text] [Related]
49. Treatment of bipolar disorder: how far have we come? Hopkins HS; Gelenberg AJ Psychopharmacol Bull; 1994; 30(1):27-38. PubMed ID: 7972626 [TBL] [Abstract][Full Text] [Related]
50. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study. Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645 [TBL] [Abstract][Full Text] [Related]
51. Electroconvulsive therapy for the treatment of organic catatonia due to viral encephalitis. Shukla L; Narayanaswamy JC; Gopinath S; Math SB J ECT; 2012 Sep; 28(3):e27-8. PubMed ID: 22914633 [TBL] [Abstract][Full Text] [Related]
52. Electroconvulsive therapy complicated by life-threatening hyperkalemia in a catatonic patient. Hudcova J; Schumann R Gen Hosp Psychiatry; 2006; 28(5):440-2. PubMed ID: 16950383 [TBL] [Abstract][Full Text] [Related]
53. Maintenance electroconvulsive therapy for depression with catatonia in a young woman with Down syndrome. Torr J; D'Abrera JC J ECT; 2014 Dec; 30(4):332-6. PubMed ID: 24755717 [TBL] [Abstract][Full Text] [Related]